Back to Search Start Over

Hemin and Cobalt Protoporphyrin Inhibit NLRP3 Inflammasome Activation by Enhancing Autophagy: A Novel Mechanism of Inflammasome Regulation

Authors :
Kari K. Eklund
Vesa-Petteri Kouri
Sampsa Matikainen
Juhani Virkanen
Ilona Kareinen
Petri T. Kovanen
Nanna Fyhrquist
Kristiina Rajamäki
Katariina Nurmi
Kirsi Vaali
Anna-Liisa Levonen
Department of Geosciences and Geography
Clinicum
Department of Bacteriology and Immunology
Medicum
Department of Medicine
Reumatologian yksikkö
University of Helsinki
HUS Internal Medicine and Rehabilitation
HUS Inflammation Center
Source :
Journal of Innate Immunity. 9:65-82
Publication Year :
2016
Publisher :
S. Karger AG, 2016.

Abstract

Inflammasomes are intracellular protein platforms, which, upon activation, produce the highly proinflammatory cytokines interleukin (IL)-1 beta and IL-18. Heme, hemin and their degradation products possess significant immunomodulatory functions. Here, we studied whether hemin regulates inflammasome function in macrophages. Both hemin and its derivative, cobalt protoporphyrin (CoPP), significantly reduced IL-1 beta secretion by cultured human primary macrophages, the human monocytic leukemia cell line and also mouse bone marrow-derived and peritoneal macrophages. Intraperitoneal administration of CoPP to mice prior to urate crystal-induced peritonitis alleviated IL-1 beta secretion to the peritoneal cavity. In cultured macrophages, hemin and CoPP inhibited NLRP3 inflammasome assembly by reducing the amount of intracellular apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC). The reduction of ASC was associated with enhanced autophagosome formation and autophagic flux. Inhibition of autophagy prevented the CoPP-induced depletion of ASC, implying that the depletion was caused by increased autophagy. Our data indicate that hemin functions as an endogenous negative regulator of the NLRP3 inflammasome. The inhibition is mediated via enhanced autophagy that results in increased degradation of ASC. This regulatory mechanism may provide a novel approach for the treatment of inflammasome-related diseases. (C) 2016 S. Karger AG, Basel

Details

ISSN :
16628128 and 1662811X
Volume :
9
Database :
OpenAIRE
Journal :
Journal of Innate Immunity
Accession number :
edsair.doi.dedup.....a0b6bb119e2f7e8d4c6f60cb8db6fd03